An innovative watercress extract, rich in isothiocyanates, designed to soothe itchy and irritated skin, particularly effective post-shaving. With proven anti-inflammatory properties, this extract offers a natural remedy for skin care applications.
Watercress Research Ltd introduces a unique watercress extract enriched with isothiocyanates, specifically phenethylisothiocyanate (PEITC), to target and soothe skin inflammation. This solution leverages the natural anti-inflammatory properties of isothiocyanates, providing an effective remedy for itchy and irritated skin, especially beneficial after shaving. The extract's potential to interact with Toll-Like receptors involved in the itch pathway underscores its efficacy in skin care.
The watercress-based isothiocyanate solution is at Technology Readiness Level 9, indicating it has been thoroughly validated and is ready for commercial deployment. Ongoing collaborations and patch testing continue to enhance its application scope.
Watercress Research Ltd is a phytochemicals-based company spun out from the University of Exeter in 2019 that specializes in the study of the biological and medicinal properties of the watercress plant (Nasturtium officinale). By applying rigorous scientific methodology and evidence-based medicine to pharmacognosy, the company develops urease inhibitory products, plant-based proteins, and diverse ingredient technologies. Their research focuses on the extraction and classification of bioactive phytochemicals, including PEITC, for applications across the cosmetics, food, drink, and pharmaceutical industries. The company is committed to scientific substantiation, ensuring that all health claims are backed by research and peer-reviewed evidence.
The company is led by a team of academics and healthcare professionals, including an NHS General Practitioner and a Professor of Experimental Medicine, who prioritize clinical rigor in their product development. Watercress Research has translated its foundational scientific studies into a consumer-facing brand, Prof & Doc, which offers a range of cosmetic products like serums and skin creams formulated with watercress extract. Supported by venture capital investment, the company is actively expanding its capabilities through the construction of bespoke processing facilities to scale its product portfolio and drive commercial adoption within the healthcare and consumer goods sectors.